John Kiely

CIK: 0001781149

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (40.0%)

Position reduction

Option Exercises (M)3 (30.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AMRX

Amneal Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

AMRX
Amneal Pharmaceuticals, Inc.
Aug 13, 2026
Sale(S)
Direct
50K shares at avg. $17.64$882K
AMRX
Amneal Pharmaceuticals, Inc.
Aug 13, 2026
Gift(G)
Direct
10K shares-
AMRX
Amneal Pharmaceuticals, Inc.
May 7, 2026
Exercise(M)
Direct
34.8K shares-
AMRX
Amneal Pharmaceuticals, Inc.
May 6, 2026
Award(A)
Restricted Stock Units
Direct
19.8K shares-
AMRX
Amneal Pharmaceuticals, Inc.
Aug 27, 2025
Sale(S)
Direct
32K shares at avg. $9.23$295K
AMRX
Amneal Pharmaceuticals, Inc.
May 12, 2025
Sale(S)
Direct
50K shares at avg. $7.59$380K
AMRX
Amneal Pharmaceuticals, Inc.
May 6, 2025
Award(A)
Restricted Stock Units
Direct
34.8K shares-
AMRX
Amneal Pharmaceuticals, Inc.
May 5, 2025
Exercise(M)
Direct
40.3K shares-
AMRX
Amneal Pharmaceuticals, Inc.
Nov 22, 2024
Sale(S)
Direct
17.1K shares at avg. $8.38$143K
AMRX
Amneal Pharmaceuticals, Inc.
Nov 22, 2024
Exercise(M)
Direct
28.5K shares at avg. $4.76$136K

		Type	Shares	Price		Ownership
Aug 13, 2026	AMRX Amneal Pharmaceuticals, Inc.	Sale(S)	50,000	$17.64	$882,000	Direct
Aug 13, 2026	AMRX Amneal Pharmaceuticals, Inc.	Gift(G)	10,000	-	$0	Direct
May 7, 2026	AMRX Amneal Pharmaceuticals, Inc.	Exercise(M)	34,819	-	$0	Direct
May 6, 2026	AMRX Amneal Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	19,824	-	-	Direct
Aug 27, 2025	AMRX Amneal Pharmaceuticals, Inc.	Sale(S)	32,000	$9.23	$295,360	Direct
May 12, 2025	AMRX Amneal Pharmaceuticals, Inc.	Sale(S)	50,000	$7.59	$379,500	Direct
May 6, 2025	AMRX Amneal Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	34,819	-	-	Direct
May 5, 2025	AMRX Amneal Pharmaceuticals, Inc.	Exercise(M)	40,258	-	-	Direct
Nov 22, 2024	AMRX Amneal Pharmaceuticals, Inc.	Sale(S)	17,058	$8.38	$142,946	Direct
Nov 22, 2024	AMRX Amneal Pharmaceuticals, Inc.	Exercise(M)	28,506	$4.76	$135,689	Direct

1-10 of 10 transactions

About Kiely John

Kiely John (SEC CIK 0001781149) files insider reports with the SEC as Director of Amneal Pharmaceuticals, Inc. (AMRX).

Signal8 holds 6 ownership filings by Kiely John, all Form 4s, filed between Nov 26, 2024 and Aug 14, 2026. Those filings report 10 transactions, from Nov 22, 2024 to Aug 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kiely John's filings is in BRIDGEWATER, NJ.

Recent filings by Kiely John

Aug 13, 2026: Open-market sale of AMRX shares (Form 4, code S).
Aug 13, 2026: Gift of AMRX shares (Form 4, code G).
May 7, 2026: Option exercise of AMRX shares (Form 4, code M).
May 6, 2026: Grant or award of AMRX derivative securities (Form 4, code A).
Aug 27, 2025: Open-market sale of AMRX shares (Form 4, code S).

Other insiders filing for Amneal Pharmaceuticals, Inc. (AMRX)

BUCHI J KEVIN, Director
BOYER ANDREW S, Executive Vice President
Shah Nikita, Executive Vice President
Daly Jason B., EVP, Chief Legal Officer
Patel Tushar Bhikhubhai, 10% Owner
Patel Chintu, Co-CEO

How to read Form 4 transaction codes